Special Diabetes Program Reauthorization Act of 2025
- Bill Number
- H.R. 5461
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-09-18: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-03-04T09:06:53Z
AI-Generated Summary
Purpose
This legislation aims to extend federal funding for Special Diabetes Programs focused on Type 1 diabetes research and related activities.
Key Provisions
- The bill amends Section 330B(b)(2) of the Public Health Service Act to authorize $160,000,000 annually for fiscal years 2026 through 2030.
- Funds are to remain available until expended.
- It updates the existing funding structure by adding a new subparagraph for these years after prior periods.
Significant Changes to Existing Law
- The amendment extends the program's authorization beyond current limits, replacing the previous end date with a five-year extension.
- No other modifications to eligibility, program operations, or oversight are introduced.
Potential Impacts
- On government agencies: Continues support for the Department of Health and Human Services in administering diabetes research programs.
- On citizens: Maintains resources for Type 1 diabetes prevention, treatment, and education efforts that benefit affected individuals and families.
- On international relations: No direct effects are outlined in the bill.
Main Stakeholders Affected
- Individuals with Type 1 diabetes and their caregivers.
- Research institutions and medical organizations conducting diabetes studies.
- Federal health agencies responsible for program implementation.
Notable Legal, Constitutional, or Political Implications
- The bill represents a routine extension of an existing public health program with no evident constitutional challenges or major legal shifts.
- It was introduced with bipartisan support in the House.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (49)
Rep. Bilirakis, Gus M. [R-FL-12], Rep. Ruiz, Raul [D-CA-25], Rep. Thompson, Bennie G. [D-MS-2], Rep. Cleaver, Emanuel [D-MO-5], Rep. Raskin, Jamie [D-MD-8], Rep. Moore, Gwen [D-WI-4], Rep. Tlaib, Rashida [D-MI-12], Rep. Joyce, David P. [R-OH-14], Rep. Doggett, Lloyd [D-TX-37], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Craig, Angie [D-MN-2], Rep. Waters, Maxine [D-CA-43], Rep. Davids, Sharice [D-KS-3], Rep. Balderson, Troy [R-OH-12], Rep. Jayapal, Pramila [D-WA-7], Rep. Underwood, Lauren [D-IL-14], Rep. McBride, Sarah [D-DE-At Large], Rep. Flood, Mike [R-NE-1], Rep. Thanedar, Shri [D-MI-13], Rep. Pocan, Mark [D-WI-2], Rep. Riley, Josh [D-NY-19], Rep. Nadler, Jerrold [D-NY-12], Rep. Wilson, Joe [R-SC-2], Rep. Goldman, Daniel S. [D-NY-10], Rep. Randall, Emily [D-WA-6], Rep. Davis, Donald G. [D-NC-1], Rep. Tenney, Claudia [R-NY-24], Rep. Scott, Robert C. "Bobby" [D-VA-3], Rep. Tran, Derek [D-CA-45], Rep. Soto, Darren [D-FL-9], Rep. Schrier, Kim [D-WA-8], Rep. McBath, Lucy [D-GA-6], Rep. DelBene, Suzan K. [D-WA-1], Rep. Moulton, Seth [D-MA-6], Rep. Williams, Nikema [D-GA-5], Rep. Friedman, Laura [D-CA-30], Rep. Pingree, Chellie [D-ME-1], Rep. Tonko, Paul [D-NY-20], Rep. Owens, Burgess [R-UT-4], Rep. Figures, Shomari [D-AL-2], Rep. Rogers, Mike D. [R-AL-3], Rep. Grothman, Glenn [R-WI-6], Rep. Lawler, Michael [R-NY-17], Rep. Sewell, Terri A. [D-AL-7], Rep. Fitzgerald, Scott [R-WI-5], Rep. Landsman, Greg [D-OH-1], Rep. Steil, Bryan [R-WI-1], Rep. Meuser, Daniel [R-PA-9], Rep. Kiggans, Jennifer A. [R-VA-2]
Recent Actions
- 2025-09-18: Referred to the House Committee on Energy and Commerce.
- 2025-09-18: Introduced in House
- 2025-09-18: Introduced in House
Bill Versions
- Special Diabetes Program Reauthorization Act of 2025 — issued 2025-09-18 — PDF (2 pages)